AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting

Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG ...

Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion

Engagement Supports Commercial Readiness Strategy for MaxYield™ and CardioYield™ in the United States TORONTO, ON / ACCESS ...

AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board

Dr. Dorian succeeds Peter Kendall, who previously served as Chair of the Medical Advisory Board. This leadership transition comes as AIML enters a phase of advanced clinical validation, regulatory ...
PharmiWeb

AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer

TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire ...
PharmiWeb

AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors

VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Michael Diamond to its ...

AI/ML Innovations Inc.: AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting

Collaboration enables deployment of MaxYield and CardioYield into third-party health systems and clinic sitesThis pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG and ...